4NY9:
reference: The Discovery of CCR1 Antagonist, BMS-817399, for the Treatment of Rheumatoid Arthritis., Santella J, Duncia JV, Gardner D, Wu H, Dhar MT, Cavallaro CL, Tebben AJ, Carter PH, Barrish JC, Yarde M, Briceno S, Cvijic ME, Grafstrom R, Liu R, Patel S, Watson A, Yang G, Rose A, Vickery R, Caceres Cortes J, Caporuscio C, Camac D, Khan J, An Y, Foster W, Davies P, Hynes J, J Med Chem. 2014 Aug 7. PMID: 25101488

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).